简介：摘要目的分析临床蛛网膜下腔出血后脑血管痉挛患者行丹红注射液穴位注射的效果.方法从我院２０１１年１月－２０１５年３月接收众多蛛网膜下腔出血患者中抽选１００例作为本次调查对象,分成两组后借助不同疗法治疗,即对照组患者行尼莫地平疗法,实验组行丹红注射液穴位注射疗法,评定临床效果.结果实验组患者临床脑血管痉挛病症发生率６．０％低于对照组２０．０％,存在差异(P＜０．０５).结论临床借助丹红注射液穴位注射疗法治疗蛛网膜下腔出血患者作用突出,可有效预防脑血管痉挛症状的发生,值得借鉴.关键词丹红注射液;穴位注射;蛛网膜下腔出血;脑血管痉挛DanredinjectionpointinjectionclinicalexplorethepreventionandtreatmentofcerebralvasospasmaftersubarachnoidhemorrhageZhangliang,tangshanluancountyinhebeiprovincepeople??shospital,０６３７００,AbstractObjectivetoanalyzeclinicalpatientswithcerebralvasospasmaftersubarachnoidhemorrhageDanredinjectioneffectofpointinjection．MethodsfromJanuary２０１１toMarch２０１１receivednumeroussubarachnoidhemorrhagepatientsselected１００casesastheinvestigationobject,isdividedintotwogroupsafＧterusingdifferenttherapy,namelythecontrolgrouppatientsnimgroundtreatment,theexperimentalgroupDanredinjectionpointinjectiontherapy,toassesstheclinicaleffect．Resultsthepatientswithcerebralvasospasmclinicaldiseaseincidenceof６．０％２０．０％lowerthanthecontrolgroup,thedifference(P＜０．０５)．ConＧclusionclinicaluseDanredinjectionpointinjectiontherapyforpatientswithsubarachnoidhemorrhageeffectisoutstanding,caneffectivelypreventthehappeningoftheKseyymwptoordmssofcerebralvasospasm,isworthusingforreference．Danredinjection;Pointinjection;Subarachnoidhemorrhage．Cerebralvasospasm中图分类号R２４６．８文献标识码B文章编号１００８－６３１５(２０１５)１２－０２６４－０２

简介：摘要目的对葛根素对动脉瘤性蛛网膜下腔出血后脑血管痉挛相关血管活性因子的影响与临床疗效进行探析.方法选择研究对象为２０１３年１月至２０１５年６月我院接诊的８０例动脉瘤性蛛网膜下腔出血患者,随机分为观察组与对照组,对照组给予常规治疗,观察组给予葛根素＋葡萄糖注射液进行治疗,对比与观察两组患者的血管活性因子检测结果、Glasgow预后评分与脑血管痉挛发生率.结果观察组患者的脑血管痉挛发生率是３５％,对照组是６７．５％,差异性显著(P＜０．０５).观察组患者的Glasgow评分是(４．５８±０．６１)分,对照组是(３．９１±０．９１)分,存在较大差异性(P＜０．０５).两组患者的血管活性因子检测结果的差异性显著(P＜０．０５).结论葛根素对动脉瘤性蛛网膜下腔出血治疗中的应用,极大的改善患者的预后,减轻患者治疗后遗症.关键词葛根素;动脉瘤性蛛网膜下腔出血;脑血管痉挛;闭阻脉络证型PuerarinonthecerebralvasospasmafteraneurysmalsubarachnoidhemorrhagerelatedtovascularactivefactorofinfluenceZhangliang,tangshanluancountyinhebeiprovincepeople＇shospital,０６３７００,AbstractobjectiveofpuerarinoncerebralvasospasmafteraneurysmalsubarachnoidhemorrhagerelatedtovascularactivefactorandtheinfluenceofcliniＧcalcurativeeffectanalysis．MethodchoosetheobjectofstudyforbetweenJanuary２０１３andJune２０１３,ourhospitaldepartmentsof８０patientswithaneurysmalsubarachnoidhemorrhage,wererandomlydividedintoobservationgroupandcontrolgroup,controlgroupgivenconventionaltreatment,theobservationgroupwasgivenpuerarin＋glucoseinjectiontreatment,thecontrastandobservationoftwogroupsofpatientswithvascularactivefactortestresults,Glasgowoutcomescoreandtheincidenceofcerebralvasospasm．Resultstheobservationgroupofpatientswithcerebralvasospasmincidencewas３５％,controlgroupis６７．５％,thedifferencesignificant(P＜０．０５)．ObservationgroupofpatientswithGlasgowscorewas(４．５８＋/－０．６１),thecontrolgroupwas(３．９１＋/－０．９１),thereisabigdifference(P＜０．０５)．Twogroupsoftestingresultsofvascularactivefactorinpatientswithsignificantdifference(P＜０．０５)．ConclusionpuerarinapplicaＧtionforthetreatmentofaneurysmalsubarachnoidhemorrhage,greatlyimprovetheprognosisofpatients,reducepatienttreatmentsequelae．KeywordsPuerarin;Aneurysmalsubarachnoidhemorrhage．Cerebralvasospasm．Closeyourcardtypethreadresistance中图分类号R７文献标识码B文章编号１００８－６３１５(２０１５)１０－０３２６－０１